Target intelligence / Profile preview

Ribosomal protein L26 pseudogene 9 (RPL26P9)

Target
RPL26P9
Molecular classification
Other (Processed pseudogene)
01

Overview

Ribosomal protein L26 pseudogene 9 (RPL26P9) is a processed pseudogene originating from the gene encoding ribosomal protein L26. Pseudogenes arise from retrotransposition or duplication events and generally do not produce functional proteins in humans. The RPL26P9 sequence shares high similarity with functional ribosomal protein L26 but does not play an active role in ribosome biology or disease. Its presence in the genome is mainly a consequence of past evolutionary events, contributing to genetic diversity but not functional biology. Pseudogenes like RPL26P9 can sometimes be mistaken for functional genes in genetic assays, but have no established role in molecular processes, disease, or therapeutics.

Other names
RPL26_2_76RPL26P9
02

Biological functions

Other (No known biological function; does not encode a functional product)
03

Disease associations

Other (No established roles in disease; functional RPL26 mutations, not pseudogenes, are associated with Diamond-Blackfan anemia)

Beyond the preview

Go deeper on Ribosomal protein L26 pseudogene 9 (RPL26P9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L26 pseudogene 9 (RPL26P9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call